willis: clonoseq for determining response in lymphoid cancers
Published 8 years ago • 120 plays • Length 2:40Download video MP4
Download video MP3
Similar videos
-
1:12:05
a practical approach to mrd: testing with clonoseq
-
2:54
clonoseq: evaluating mrd in cll
-
30:46
asco 2021 clonoseq industry expert theater
-
1:49
an update on the ‘watch’ registry: clonoseq® mrd monitoring in b-cell malignancies
-
2:33
clonoseq: what is mrd
-
1:20
clonoseq® as a tool to measure mrd negativity
-
1:25
the use of clonoseq to monitor mrd in patients with lbcl treated with axi-cel in zuma-7
-
5:59
all4cure discusses clonoseq testing
-
0:25
will liquid biopsy-based approaches replace traditional pathological markers for bladder cancer?
-
4:11
using ctcs to determine minimal residual disease in gi cancers
-
0:26
what is the best screening test for colorectal cancer? - dr. john kisiel
-
2:09
karen: multiple myeloma patient discusses clonoseq® mrd testing (2 minute version)
-
2:31
correlation between synaptic biomarkers and known csf biomarkers in alzheimer’s disease
-
5:03
overdiagnosis of cancer, defined
-
2:07
tiffany: a multiple myeloma patient tells her clonoseq® mrd testing story (2 minute version)
-
1:42
dr. lazarus on the importance of companion diagnostics
-
1:15
dll3, a new biomarker for neuroendocrine tumors of the lung
-
1:22
the current and future uses of the immunoscore
-
0:46
sequencing adcs and finding novel biomarkers for urothelial carcinoma